Dr. Reddy's Laboratories Ltd. Earnings

Dr. Reddy's Laboratories Ltd.’s revenue jumped 20.09% since last year same period to $85060Mn in the Q1 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 1.76% jump in its revenue since last 3-months.

Dr. Reddy's Laboratories Ltd.’s net profit jumped 21.94% since last year same period to $15938Mn in the Q1 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 12.77% jump in its net profits since last 3-months.

Dr. Reddy's Laboratories Ltd.’s net profit margin jumped 1.54% since last year same period to 18.74% in the Q1 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 10.82% jump in its net profit margins since last 3-months.

Dr. Reddy's Laboratories Ltd.’s price-to-earnings ratio after this Q1 2025 earnings stands at 19.23.

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current quarter stand at 17.13 - a 6.06% jump from last quarter’s estimates.

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current year stand at 17.13.

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) fell -75.61% since last year same period to 19.11 in the Q1 2025. This indicates that the Dr. Reddy's Laboratories Ltd. has generated -75.61% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Dr. Reddy's Laboratories Ltd.’s return on assets (ROA) stands at 0.1.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Dr. Reddy's Laboratories Ltd.’s return on equity (ROE) stands at 0.19.